GEHCS&P 500

GE HealthCare SEC filings, summarized

We read every GE HealthCare 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.

Track GEHC in your inbox

Add GE HealthCare to your watchlist — free, every morning.

Subscribe free

Recent filings

8-KSeptember 22, 2026

GE HealthCare appoints AT&T CFO Pascal Desroches to its board

GE HealthCare appointed Pascal Desroches, AT&T’s senior executive vice president and CFO, to its Board of Directors effective January 4, 2027. Desroches,…

8-KSeptember 22, 2026

GE HealthCare appoints AT&T CFO Pascal Desroches to its board

GE HealthCare appointed Pascal Desroches, AT&T’s senior executive vice president and CFO, to its Board of Directors effective January 4, 2027. Desroches,…

8-KAugust 18, 2026

GE HealthCare appoints William Grogan as CFO effective September 14

GE HealthCare appointed William K. Grogan, 48, as chief financial officer effective September 14, 2026, succeeding interim CFO George Newcomb, who will…

8-KJuly 29, 2026

GE HealthCare recasts results under new Advanced Imaging Solutions segment

GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new Advanced Imaging Solutions segment in the second quarter of…

8-KJuly 29, 2026

GE HealthCare reports 5.7% second-quarter revenue growth and reaffirms 2026 outlook

GE HealthCare reported second-quarter 2026 revenue of $5.3 billion, up 5.7% year over year, with diluted EPS rising 16.5% to $1.24 and adjusted EPS…

8-KJuly 23, 2026

GE HealthCare names interim CFO as Saccaro resigns, reports Q2 revenue growth

GE HealthCare said CFO James K. (Jay) Saccaro will leave on August 14, 2026, for a role outside medical technology, with Controller and Chief Accounting…

8-KJuly 23, 2026

GE HealthCare reports 5.7% preliminary revenue growth and CFO transition

GE HealthCare expects second-quarter 2026 revenue of $5.295 billion, up 5.7% year over year, including 3.5% organic growth, while diluted EPS and adjusted…

8-KMarch 17, 2026

GE HealthCare ($GEHC) filed a Form 8‑K on Mar 17, 2026 furnishing Exhibit 99 (press release dated Mar 17,…

GE HealthCare ($GEHC) filed a Form 8‑K on Mar 17, 2026 furnishing Exhibit 99 (press release dated Mar 17, 2026) and Exhibit 104 (Inline XBRL cover page).…

8-KMarch 17, 2026

GE HealthCare appointed Kevin A.

GE HealthCare appointed Kevin A. Lobo to its Board, effective March 17, 2026; press release furnished as Exhibit 99. Investors should review the company…

8-KMarch 17, 2026

Kevin A.

Kevin A. Lobo appointed to GE HealthCare board effective Mar 13, 2026; term runs to the 2026 Annual Meeting. Joins Talent, Culture & Compensation Committee.…

8-KFebruary 4, 2026

GE HealthCare filed an 8‑K on Feb 4, 2026 furnishing two exhibits: Exhibit 99 — press release (Feb 4,…

GE HealthCare filed an 8‑K on Feb 4, 2026 furnishing two exhibits: Exhibit 99 — press release (Feb 4, 2026) and Exhibit 104 — Inline XBRL cover page. Only…

8-KFebruary 4, 2026

GE HealthCare ($GEHC) on Feb 4, 2026 issued a press release announcing its Q4 2025 and fiscal year ended…

GE HealthCare ($GEHC) on Feb 4, 2026 issued a press release announcing its Q4 2025 and fiscal year ended Dec 31, 2025 financial results; press release…